Exact Diagnostics launches EDX respiratory panel control for use with molecular-based clinical assays

The EDX RP Positive Run Control aims to monitor the performance of clinical respiratory assays

27 Feb 2020
Diane Li
Assistant Editor

Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, has announced that Exact Diagnostics, a company that Bio-Rad acquired in the third quarter of 2019, has launched EDX RP Positive Run Control, an unassayed external quality control intended to monitor the performance of clinical respiratory assays.

Routine use of EDX RP Positive Run Control allows laboratories to meet their individualized quality control goals, including evaluation of reagent lot changes and new shipments. In addition, it monitors multiple identical devices and provides an assessment of different personnel and locations.

The EDX RP Positive Run Control contains 22 respiratory analytes that are internally value-assigned using Bio-Rad’s Digital Droplet PCR technology. The new multiplex control is a combination of whole, intact virus and bacteria samples that have been heated or chemically inactivated, as well as synthetic RNA transcripts. The control is designed to test the entire process of a molecular assay including extraction, detection, and amplification. EDX RP Positive Run Control is the first multi-analyte control to target 22 analytes in a single vial, which can save laboratories time and space on their instruments.

Do you use Bio-Rad products in your lab? Write a review today for your chance to win a $400 Amazon gift card>>